Coronary angioscopic imaging of in-stent restenosis after biolimus-eluting coronary stent implantation

Antimicrobial and Antibiofilm Effects of Peptides from Venom of Social Wasp and Scorpion on Multidrug-Resistant Acinetobacter baumannii

“…The use of drugs to coat stents drastically reduces the process of re-stenosis [14,15]. Its expandable metal composition, whether coated with any drug or not, has a structure comprising a metal core of cobalt–chromium alloy or stainless steel and on the outside may have a coating of two polymers, lactic acid-co-glycolic acid (PLGA) or polylactic acid (PLA) that, in turn, can be manipulated to have additional drugs or antibodies integrated [16,17,18]. Some of the most commonly used drugs in stents are immunosuppressants, such as sirulimus, to reduce the risk of stent thrombosis caused by cell rejection [17].…”

Editorial: Remaining issue after drug-eluting stent implantation: Histopathological mechanisms of early-phase in-stent restenosis

“…On the other hand, the main cause of early-phase ISR in DES remains unclear. In this issue of the Journal of Cardiology Cases , Ito et al report a case of coronary angioscopic imaging of early-phase ISR after biolimus-eluting coronary stent implantation [10] . Coronary angioscopy is an endoscopic technology allowing direct visualization of the surface color and superficial morphology of ISR lesions.…”